BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28726020)

  • 1. Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.
    Azizieh FY; Al Jarallah K; Shehab D; Gupta R; Dingle K; Raghupathy R
    Rheumatol Int; 2017 Oct; 37(10):1727-1734. PubMed ID: 28726020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease activity and cytokine production in mitogen-stimulated peripheral blood mononuclear cells from patients with rheumatoid arthritis.
    Uppal SS; Raghupathy R; Hayat SJ; Longenecker JC; Abraham M; Rawoot P
    Med Princ Pract; 2010; 19(1):33-9. PubMed ID: 19996617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis.
    Kanik KS; Hagiwara E; Yarboro CH; Schumacher HR; Wilder RL; Klinman DM
    J Rheumatol; 1998 Jan; 25(1):16-22. PubMed ID: 9458197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
    Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
    Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.
    Ruschen S; Stellberg W; Warnatz H
    Clin Exp Immunol; 1992 Jul; 89(1):32-7. PubMed ID: 1385767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.
    Pahwa R; Kumar U; Das N
    Mol Cell Biochem; 2016 Mar; 414(1-2):85-94. PubMed ID: 26906204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of proliferation and pro-inflammatory cytokine production in rheumatoid arthritis peripheral blood mononuclear cells by a 65 KDa chondrocyte membrane-specific, constitutive target autoantigen (CH65).
    Alsalameh RJ; Casey RC; Mollenhauer J; Kalden JR; Burmester GR; Alsalameh SM
    Int J Rheum Dis; 2017 Sep; 20(9):1132-1141. PubMed ID: 24131486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
    De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
    J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).
    Bucht A; Larsson P; Weisbrot L; Thorne C; Pisa P; Smedegård G; Keystone EC; Grönberg A
    Clin Exp Immunol; 1996 Mar; 103(3):357-67. PubMed ID: 8608632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of the cytokinome in undifferentiated arthritis progressing to rheumatoid arthritis and its change in the course of therapy. Move toward personalized medicine.
    Brzustewicz E; Bzoma I; Daca A; Szarecka M; Bykowska MS; Witkowski JM; Bryl E
    Cytokine; 2017 Sep; 97():1-13. PubMed ID: 28551592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis.
    Chovanova L; Vlcek M; Krskova K; Penesova A; Radikova Z; Rovensky J; Cholujova D; Sedlak J; Imrich R
    Gen Physiol Biophys; 2013 Sep; 32(3):395-404. PubMed ID: 23817641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
    Hernández-Palma LA; García-Arellano S; Bucala R; Llamas-Covarrubias MA; De la Cruz-Mosso U; Oregon-Romero E; Cerpa-Cruz S; Parra-Rojas I; Plascencia-Hernández A; Muñoz-Valle JF
    Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different cytokine profiles in patients with chronic and acute reactive arthritis.
    Butrimiene I; Jarmalaite S; Ranceva J; Venalis A; Jasiuleviciute L; Zvirbliene A
    Rheumatology (Oxford); 2004 Oct; 43(10):1300-4. PubMed ID: 15266062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
    García-Arellano S; Hernández-Palma LA; Bucala R; Hernández-Bello J; De la Cruz-Mosso U; García-Iglesias T; Cerpa-Cruz S; Padilla-Gutiérrez JR; Valle Y; Soñanez-Organis JG; Parra-Rojas I; Pereira-Suárez AL; Muñoz-Valle JF
    Curr Mol Med; 2018; 18(10):679-688. PubMed ID: 30698113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
    Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
    Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.
    Schulze-Koops H; Lipsky PE; Kavanaugh AF; Davis LS
    J Immunol; 1995 Nov; 155(10):5029-37. PubMed ID: 7594511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines.
    Xia L; Shen H; Lu J
    Cytokine; 2015 Dec; 76(2):553-557. PubMed ID: 26159110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.